Drug Trial Radar · NCT05923515
A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Last checked: Nov 20, 2026Latest source record: Jun 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
78
Planned (sponsor's estimate)
Start
May 22, 2023
Primary completion
Apr 30, 2025
Study completion May 1, 2025
Sponsor
- Lead sponsor
- JemincareIndustry
- Sponsor type
- Industry
- Collaborators
- Zhejiang Hangyu Pharmaceutical Co., Ltd.
- First posted
- Jun 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase I, Open, Multicenter Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion
Conditions
- Malignant Pleural Effusion
Interventions
JMKX000197Drug
for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of dose limiting toxicityTime frame: Up to approximately 7 days at each dose level
- Maximum tolerated doseTime frame: Up to approximately 24 months
- Recommended Phase II doseTime frame: Up to approximately 24 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Zhongnan Hospital of Wuhan University
Wuhan, Hubei, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.